Navigation Links
Chromosomal problems affect nearly all human embryos
Date:7/1/2009

significant evidence that it does, in fact, increase live birth rates after IVF. Our findings have shown that almost every cell of a human embryo carries a different genetic composition; consequently, the one cell that is analysed genetically is not representative of the rest of the embryo. If the tested cell is genetically abnormal, the embryo will not be transferred. But the rest of the embryo might be normal and develop into a healthy person. Therefore, the use of PGS means that potentially viable embryos will be discarded. The prevalent chromosomal instability in all early human IVF embryos explains the failure of PGS to improve the live birth rate per embryo transferred.

"I think that we have made a crucial breakthrough that will change the way we do preimplantation genetic diagnosis and PGS and help to advance our ability to improve human fertility," said Ms Vanneste.


'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New test can detect both genetic and chromosomal abnormalities in embryos
2. Physician-scientists seek solutions to reproductive problems related to chromosomal variations
3. Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further study
4. Queens researchers shine light on compact fluorescent bulb problems
5. Children who are dissatisfied with their appearance often have problems with their peer group
6. Duke forum to address global engineering problems
7. Maternal health problems in Myanmar widespread
8. MSU researcher studies ties between cholesterol drugs, muscle problems
9. Replacing the coach doesnt solve problems
10. Sounding out heart problems automatically
11. Can microorganisms be a solution to the worlds energy problems?

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...t the Brain Research Centre, a partnership of the ... and Vancouver Coastal Health Research Institute, ... by which brain cells die following a stroke, as w... results of the study were recently published onli...any brain cells continue to die even after blood f...
(Date:11/20/2009)...h report published in the November 2009 issue of t... scientists show how a family of genes (1-aminocyc...e responsible for production of ethylene. This gas...is information lays the foundation for future gene...sistant, able to survive and thrive in difficult t...
(Date:11/20/2009)..., a group of University of Oklahoma researchers we...f the human genome project. Today, the OU Advanc... an international effort to sequence the tomato ge...onal Science Foundation for plant genomics. , "...so improving the tomato and crop yields will impro...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2It's a gas: New discovery may lead to heartier, high-yielding plants 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Wound Management Technologies Announces Clinical Study Presentation of CellerateRx 28R 29 Technology at Leading Skin and Wound Care Conference 59625 1Wound Management Technologies Announces Clinical Study Presentation of CellerateRx 28R 29 Technology at Leading Skin and Wound Care Conference 59625 2Wound Management Technologies Announces Clinical Study Presentation of CellerateRx 28R 29 Technology at Leading Skin and Wound Care Conference 59625 3avVaa World Health Care Products Inc Announces Access via Social Media Websites 14507 1avVaa World Health Care Products Inc Announces Access via Social Media Websites 14507 2Carriage Services Announces Third Quarter Earnings Release and Conference Call Schedule 59622 1Carriage Services Announces Third Quarter Earnings Release and Conference Call Schedule 59622 2Carriage Services Announces Third Quarter Earnings Release and Conference Call Schedule 59622 3
...zzaniga, professor of psychology at UC Santa Barba...f the Mind, has received the Humboldt Research Pri...nce. , "Professor Gazzaniga is a true pioneer in ...tal human questions about the relationship between...ng. "The Humboldt Research Prize is a prestigious ...
...g up in Brooklyn, NY, UC Riverside,s Jerome Schul...home to peer into a microscope to examine slides o... Over the years, that early interest in science ev... the intersection of biology and engineering tha...IChE ), in celebrating its centennial this year, h...
...study finds that genes significantly affect variat...asons why people vote and participate in the polit...al scientists James H. Fowler, Christopher T. Dawe...r (of University of Southern California), appears ...e Review , a journal of the American Political Sci...
Other Biology News:Neuroscientist Michael Gazzaniga awarded Humboldt Prize 2UC Riverside bioengineer receives high honor from chemical engineers 2UC Riverside bioengineer receives high honor from chemical engineers 3UC Riverside bioengineer receives high honor from chemical engineers 4Why do people vote? Genetic variation in political participation 2
(Date:11/20/2009)... Dendreon Corporation (N...and Drug Administration (FDA) provided written ack...License Application (BLA) for PROVENGE® (sipu...igned a Prescription Drug User Fee Act (PDUFA) dat... Dendreon,s amended BLA. Dendreon is seeking lice...
(Date:11/20/2009)...TTLER TOLEDO recently announced that Dr. Dominique...Role of Process Analytical Technology (PAT) in Gre...ber 1, 2009. , (PRWEB) No... Analytical Technology (PAT) in Green Chemistry an...s Analytical Technology (PAT) case studies will be...
(Date:11/19/2009)...SDA, Md., Nov. 19 Spheri...iotechnology for diabetes therapy, and a provider ... food, supplement, biotechnology and pharmaceutica...sly reported $6.3 million registered direct placem... of its common stock and warrants to purchase up t...
(Date:11/19/2009)... /PRNewswire/ - Aegera Therapeutics Inc. announced...ized Phase 2B study of AEG35156, a targeted antise...ple oncology indications. ,, The study, entitle...-Linked Inhibitor of Apoptosis (XIAP) Antisense AE...ine and Idarubicin in AML Following Failure of a S...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...., March 31 ImaRx Therapeutics, Inc., a,biopharma...erapies for,vascular disorders, today provided a c... year 2007 financial results., 2007 Year in Revi...dy -- Received FDA approval to market urokinase ... strategic licensing agreement with Bracco Interna...
...erformance Meets Simplicity for Routine and Resear...O ALTO, Calif., March 31 Varian, Inc.,(NasdaqGS: ...IR (Fourier,Transform Infrared) spectrometers, mic...es a range of products for both routine analyses a...scopy provides a simple, fast analytical tool to i...
...lif., March 31 Immunosyn,Corporation (OTC Bulleti...ined exclusive worldwide marketing, sales and dist...has announced its results for the fiscal,year endi...r 31, 2007, the company incurred $647,000 in,gener...rest expense which,was funded from advances by aff...
Other Biology Technology:ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 2ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 3ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 4ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 5ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 6ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 7ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 8ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 9ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007 10New FT-IR Spectrometer Series from Varian, Inc. 2Immunosyn Corporation Announces 2007 Results, Files 10KSB 2Immunosyn Corporation Announces 2007 Results, Files 10KSB 3
MUTAN SUPER EXPRESS KM 20 RXN from Takara Mirus Bio
...the 9, 10, 12, and 13 positions. It is intended fo...on of 13(S)-HODE by GC- or LC-mass spectrometry. 1...id with plant and mammalian lipoxygenases. It has ...to the endothelium at concentrations around 1 �...
... are recommended for protein expression from pTriE...tion has been selected based on rapid, vigorous ce...ved specifically with baculoviruses derived from t...-Plaque Sf9 Cells and BacVector Insect Cell Medium...
Adaptor BamH I-Sma I from Takara Mirus Bio
Biology Products: